Donald Siegel

20PUBLICATIONS
150CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapyPredictive and prognostic markersMolecular targetsHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Aug 10, 2026
Decade-long persistence of CD19 CAR T cells in B cell lymphomas.

|Jul 10, 2026
HIV-specific and resistant CAR T cells promote control of HIV replication in people with HIV.

|May 05, 2026
Rab5 improves CAR T cell efficacy via reducing fratricide and maintaining surface CAR levels.

|Mar 10, 2026
Predictive biomarkers of response to chimeric antigen receptor (CAR) T-cell therapy for pan-haematologic cancer.

Gregory M Chen, Ankita Jain, David T Gering

|Oct 21, 2025
CCR5-targeted allogeneic gamma-delta CD19 chimeric antigen receptor T cells for HIV-associated B cell-malignancy immunotherapy.

Ángel Ramírez-Fernández, Alexander J Dimitri, Fang Chen

|Aug 06, 2025
Engineering a Juxtamembrane-Targeting CAR T-Cell Against Mesothelin: A Novel Binder Resilient to Shed Antigen in Ovarian and Pancreatic Cancer.

John Scholler, Ai Song, Mansi Deshmukh

Pageof 4

Frequent Collaborators

15 joint publications

Carl H June

11 joint publications

Elizabeth O Hexner

10 joint publications

Joseph Fraietta

8 joint publications

Bruce L Levine